140 related articles for article (PubMed ID: 30076933)
1. MRGBP promotes AR-mediated transactivation of KLK3 and TMPRSS2 via acetylation of histone H2A.Z in prostate cancer cells.
Ito S; Kayukawa N; Ueda T; Taniguchi H; Morioka Y; Hongo F; Ukimura O
Biochim Biophys Acta Gene Regul Mech; 2018 Aug; ():. PubMed ID: 30076933
[TBL] [Abstract][Full Text] [Related]
2. Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer.
Valdés-Mora F; Gould CM; Colino-Sanguino Y; Qu W; Song JZ; Taylor KM; Buske FA; Statham AL; Nair SS; Armstrong NJ; Kench JG; Lee KML; Horvath LG; Qiu M; Ilinykh A; Yeo-Teh NS; Gallego-Ortega D; Stirzaker C; Clark SJ
Nat Commun; 2017 Nov; 8(1):1346. PubMed ID: 29116202
[TBL] [Abstract][Full Text] [Related]
3. Seleno-aspirin compound AS-10 promotes histone acetylation ahead of suppressing androgen receptor transcription, G1 arrest, and apoptosis of prostate cancer cells.
Karelia DN; Kim S; Plano D; Sharma AK; Jiang C; Lu J
Prostate; 2023 Jan; 83(1):16-29. PubMed ID: 35996318
[TBL] [Abstract][Full Text] [Related]
4. Metformin alters H2A.Z dynamics and regulates androgen dependent prostate cancer progression.
Tyagi M; Cheema MS; Dryhurst D; Eskiw CH; Ausió J
Oncotarget; 2018 Dec; 9(97):37054-37068. PubMed ID: 30651935
[TBL] [Abstract][Full Text] [Related]
5. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.
Weber H; Ruoff R; Garabedian MJ
PLoS Genet; 2021 Jan; 17(1):e1008540. PubMed ID: 33513133
[TBL] [Abstract][Full Text] [Related]
6. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
[TBL] [Abstract][Full Text] [Related]
7. USP10 deubiquitylates the histone variant H2A.Z and both are required for androgen receptor-mediated gene activation.
Draker R; Sarcinella E; Cheung P
Nucleic Acids Res; 2011 May; 39(9):3529-42. PubMed ID: 21245042
[TBL] [Abstract][Full Text] [Related]
8. ING3 promotes prostate cancer growth by activating the androgen receptor.
Nabbi A; McClurg UL; Thalappilly S; Almami A; Mobahat M; Bismar TA; Binda O; Riabowol KT
BMC Med; 2017 May; 15(1):103. PubMed ID: 28511652
[TBL] [Abstract][Full Text] [Related]
9. MRGBP promotes colorectal cancer metastasis via DKK1/Wnt/β-catenin and NF-kB/p65 pathways mediated EMT.
Long X; Hu Y; Duan S; Liu X; Huang W; Liu X; Xu Q; Song W; Zhou J
Exp Cell Res; 2022 Dec; 421(1):113375. PubMed ID: 36208716
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.
Jia L; Kim J; Shen H; Clark PE; Tilley WD; Coetzee GA
Mol Cancer Res; 2003 Mar; 1(5):385-92. PubMed ID: 12651911
[TBL] [Abstract][Full Text] [Related]
11. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
[TBL] [Abstract][Full Text] [Related]
12. Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor.
Gaughan L; Logan IR; Cook S; Neal DE; Robson CN
J Biol Chem; 2002 Jul; 277(29):25904-13. PubMed ID: 11994312
[TBL] [Abstract][Full Text] [Related]
13. C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer.
Yamaguchi K; Sakai M; Shimokawa T; Yamada Y; Nakamura Y; Furukawa Y
Br J Cancer; 2010 Jan; 102(2):325-31. PubMed ID: 20051959
[TBL] [Abstract][Full Text] [Related]
14. Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells.
Andreu-Vieyra C; Lai J; Berman BP; Frenkel B; Jia L; Jones PA; Coetzee GA
Mol Cell Biol; 2011 Dec; 31(23):4648-62. PubMed ID: 21969603
[TBL] [Abstract][Full Text] [Related]
15. Tip60-mediated H2A.Z acetylation promotes neuronal fate specification and bivalent gene activation.
Janas JA; Zhang L; Luu JH; Demeter J; Meng L; Marro SG; Mall M; Mooney NA; Schaukowitch K; Ng YH; Yang N; Huang Y; Neumayer G; Gozani O; Elias JE; Jackson PK; Wernig M
Mol Cell; 2022 Dec; 82(24):4627-4646.e14. PubMed ID: 36417913
[TBL] [Abstract][Full Text] [Related]
16. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
Kang Z; Jänne OA; Palvimo JJ
Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
[TBL] [Abstract][Full Text] [Related]
17. Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation.
Baumgart SJ; Nevedomskaya E; Lesche R; Newman R; Mumberg D; Haendler B
Mol Oncol; 2020 Sep; 14(9):2022-2039. PubMed ID: 32333502
[TBL] [Abstract][Full Text] [Related]
18. MRG Proteins Are Shared by Multiple Protein Complexes With Distinct Functions.
Devoucoux M; Roques C; Lachance C; Lashgari A; Joly-Beauparlant C; Jacquet K; Alerasool N; Prudente A; Taipale M; Droit A; Lambert JP; Hussein SMI; Côté J
Mol Cell Proteomics; 2022 Jul; 21(7):100253. PubMed ID: 35636729
[TBL] [Abstract][Full Text] [Related]
19. Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.
Dart DA; Brooke GN; Sita-Lumsden A; Waxman J; Bevan CL
Oncogene; 2012 Oct; 31(43):4588-98. PubMed ID: 22179832
[TBL] [Abstract][Full Text] [Related]
20. JAZF1, A Novel p400/TIP60/NuA4 Complex Member, Regulates H2A.Z Acetylation at Regulatory Regions.
Procida T; Friedrich T; Jack APM; Peritore M; Bönisch C; Eberl HC; Daus N; Kletenkov K; Nist A; Stiewe T; Borggrefe T; Mann M; Bartkuhn M; Hake SB
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
